Cellatoz Therapeutics, Inc. is working on the development and commercialization of RMAT (Regenerative Medicine Advanced Therapy) products including mainly cell therapies in order to provide patients suffering from intractable diseases with fundamental treatments of such diseases employing ‘regenerative therapeutic cells’.
We seek and discover novel cells able to be used as therapeutic agents by itself and/or in combinations with other matrix and therapeutic components. Further, we study characteristics of those cells deeply and explore novel technologies to differentiate and culture those therapeutic cells with safety.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.